All
Search
Images
Videos
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
FDA June 2024: Key Approvals and Designations Propel Oncological
…
Jul 2, 2024
targetedonc.com
Drawing Comparisons for Relevant Therapies in Patients With DLBCL
8 months ago
targetedonc.com
Trastuzumab Deruxtecan Shows Clinical Activity in HER2 Solid Tu
…
Aug 7, 2023
targetedonc.com
Mechanism of Action Compared With Other Alkylating Agents
9 months ago
targetedonc.com
The Targeted Pulse: Adagrasib Bests Docetaxel in Pretreated KR
…
11 months ago
targetedonc.com
SWOG S1826: Frontline N-AVD vs BV-AVD in Advanced Hodgkin’s L
…
Aug 31, 2023
targetedonc.com
Atezolizumab/Bevacizumab for HCC: Toxicity Management
Nov 5, 2020
targetedonc.com
CHRYSALIS-2: Amivantamab Lazertinib in Non–Small Cell Lung
…
Sep 21, 2023
targetedonc.com
Navigating ICI Plus TKI Combinations for First-Line mRCC
…
10 months ago
targetedonc.com
Choosing BTK Inhibitors Versus Venetoclax as First-Line CLL Ther
…
Apr 1, 2022
targetedonc.com
Trimodality Therapy Plus Atezolizumab Investigated for Bla
…
May 5, 2022
targetedonc.com
Rationale for Evaluating STING Agonists in Head and Neck Cancer
Apr 27, 2020
targetedonc.com
The Targeted Pulse: FDA Approvals, Real-World Insights, and Precisio
…
1 month ago
targetedonc.com
Nirogacestat Shows Statistically Significant Improvements in Desm
…
Nov 28, 2023
targetedonc.com
Safety Challenges of Oncolytic Virus Therapy
Jun 12, 2024
targetedonc.com
The Role of Menin Inhibitors in AML
Nov 1, 2022
targetedonc.com
An Introduction to Front-line Nivolumab/Ipilimumab Therapy fo
…
7 months ago
targetedonc.com
Second-Line Therapy in Advanced HCC: Treatment Considerations a
…
4 months ago
targetedonc.com
JAK V617F Monitoring and Risk Assessment Tools: Optimizing Tre
…
5 months ago
targetedonc.com
Options for MRD Testing Affect Patient Treatment Plan in Lung Ca
…
7 months ago
targetedonc.com
HR /HER2- Metastatic Breast Cancer: An Evolving Treatment Pa
…
Jul 12, 2023
targetedonc.com
INAVO120: Inavolisib Combination Therapy in PIK3CA-Mutated Breas
…
Jun 17, 2024
targetedonc.com
Unmet Needs Persist for Patients with Melanoma
Jul 13, 2024
targetedonc.com
DeFi Trial Update Shows Nirogacestat's Efficacy in Desmoi
…
5 months ago
targetedonc.com
Five-Year Data Confirm Benefit of Nivolumab in Upper GI Cancer
6 months ago
targetedonc.com
ESMO 2024: Updates in NIAGARA Study
11 months ago
targetedonc.com
Biomarkers Have Potential to Shape Treatment of RCC
5 months ago
targetedonc.com
Targeted Vaccine Leads to Broad Immune Response in Pancreatic C
…
1 week ago
targetedonc.com
Therapeutic options for a patient with mCRPC after ADT docetaxel
6 months ago
targetedonc.com
Results from CROWN: Lorlatinib in Treatment-Naïve Patients with Adv
…
Jun 11, 2024
targetedonc.com
See more videos
More like this
Feedback
Feedback